On 5 May 2021, the President of the Thai-Norwegian Chamber of Commerce attended a special session of the President’s Council of the Joint Foreign Chambers of Commerce on the COVID-19 situation and accessibility to vaccines for foreign chamber members. In order to avoid speculation, we share the below summary of the Vaccination Plan with all of our members.
Summary of the Vaccination Plan
- Joint Standing Committee on Commerce, Industry, and Banking (JSCCIB) met with the prime minister last week and give full support to the government.
- Currently, the vaccine procurement is at the G2G level only.
- The government has a responsibility to purchase the highest quantity of vaccines possible
- At least 100 million doses will be procured within this year.
- 63 million doses are procured under G2G agreements. 61 million doses will be supplied by Astra Zeneca, which is made in Thailand. The certification is in the last phase of approval and will be released to the government in June. Another 2 million doses are from Sinovac. 37 million doses will be acquired from other manufacturers such as Pfizer, Johnson and Johnson, etc.
- The aim is to vaccinate 10 – 15 million people per month or 300,000 – 500,000 people per day, starting from June.
- The Board of Trade supports the government in terms of venues and distribution of the vaccine.
- There will be no discrimination between Thais and foreigners.
- The first priority group for vaccination is people living in the “Dark Red” zone (dangerous zone) with the most infections.
- The second priority groups are elderly people over the age of 60 and those with underlying illnesses.
- The rest of the population will be vaccinated thereafter.
- The different types of vaccines will be used to suit the safety of the appropriate age groups.
- 3 million doses are reserved for the foreign community incl. foreign workers.
- The foreign community may receive the vaccine in the third or fourth quarter of 2021, but those with Thai spouses may receive the vaccination earlier.
- The request to prioritise foreign investors/businesses is sent to BOI. JFCCT awaits feedback.
- In May, all the medical staff will be vaccinated.
- Alternatively, there are attempts from private hospitals to purchase vaccines from Moderna and Sinopharm through FDA.
- The FDA-approved vaccines are Astra Zeneca, Sinovac and Johnson & Johnson.
- The vaccines under the FDA approval process are Moderna, Covaxin, Sputnik V and Pfizer BioNTech
- Chulalongkorn University and Mahidol University are developing local vaccines, expected to be released early next year. These vaccines are now undergoing the second stage of trials.
For other interesting articles from our members and chamber activities, please visit our website.